Download - Trattamento neoadiuvante del carcinoma mammario …web2.sacrocuore.it/oncologia/canoa2015/VENERDI_10... · Migration Differentiation Apoptosis Trastuzumab ... Pathologic complete

Transcript

Page 1: Trattamento neoadiuvante del carcinoma mammario …web2.sacrocuore.it/oncologia/canoa2015/VENERDI_10... · Migration Differentiation Apoptosis Trastuzumab ... Pathologic complete

Antonino Musolino

U.O.C. Oncologia Medica

Azienda Ospedaliero-Universitaria di Parma

Progetto CANOA

Ospedaletto di Pescantina, 10 Aprile 2015

Trattamento neoadiuvante del carcinoma mammario HER2-positivo/recettori ormonali positivi

- Lo studio TBCRC023 -

Page 2: Trattamento neoadiuvante del carcinoma mammario …web2.sacrocuore.it/oncologia/canoa2015/VENERDI_10... · Migration Differentiation Apoptosis Trastuzumab ... Pathologic complete

Page 3: Trattamento neoadiuvante del carcinoma mammario …web2.sacrocuore.it/oncologia/canoa2015/VENERDI_10... · Migration Differentiation Apoptosis Trastuzumab ... Pathologic complete

Page 4: Trattamento neoadiuvante del carcinoma mammario …web2.sacrocuore.it/oncologia/canoa2015/VENERDI_10... · Migration Differentiation Apoptosis Trastuzumab ... Pathologic complete

Page 5: Trattamento neoadiuvante del carcinoma mammario …web2.sacrocuore.it/oncologia/canoa2015/VENERDI_10... · Migration Differentiation Apoptosis Trastuzumab ... Pathologic complete

Page 6: Trattamento neoadiuvante del carcinoma mammario …web2.sacrocuore.it/oncologia/canoa2015/VENERDI_10... · Migration Differentiation Apoptosis Trastuzumab ... Pathologic complete

Page 7: Trattamento neoadiuvante del carcinoma mammario …web2.sacrocuore.it/oncologia/canoa2015/VENERDI_10... · Migration Differentiation Apoptosis Trastuzumab ... Pathologic complete

Page 8: Trattamento neoadiuvante del carcinoma mammario …web2.sacrocuore.it/oncologia/canoa2015/VENERDI_10... · Migration Differentiation Apoptosis Trastuzumab ... Pathologic complete

Page 9: Trattamento neoadiuvante del carcinoma mammario …web2.sacrocuore.it/oncologia/canoa2015/VENERDI_10... · Migration Differentiation Apoptosis Trastuzumab ... Pathologic complete

Page 10: Trattamento neoadiuvante del carcinoma mammario …web2.sacrocuore.it/oncologia/canoa2015/VENERDI_10... · Migration Differentiation Apoptosis Trastuzumab ... Pathologic complete

Page 11: Trattamento neoadiuvante del carcinoma mammario …web2.sacrocuore.it/oncologia/canoa2015/VENERDI_10... · Migration Differentiation Apoptosis Trastuzumab ... Pathologic complete

Page 12: Trattamento neoadiuvante del carcinoma mammario …web2.sacrocuore.it/oncologia/canoa2015/VENERDI_10... · Migration Differentiation Apoptosis Trastuzumab ... Pathologic complete

Page 13: Trattamento neoadiuvante del carcinoma mammario …web2.sacrocuore.it/oncologia/canoa2015/VENERDI_10... · Migration Differentiation Apoptosis Trastuzumab ... Pathologic complete

Page 14: Trattamento neoadiuvante del carcinoma mammario …web2.sacrocuore.it/oncologia/canoa2015/VENERDI_10... · Migration Differentiation Apoptosis Trastuzumab ... Pathologic complete

Page 15: Trattamento neoadiuvante del carcinoma mammario …web2.sacrocuore.it/oncologia/canoa2015/VENERDI_10... · Migration Differentiation Apoptosis Trastuzumab ... Pathologic complete

Page 16: Trattamento neoadiuvante del carcinoma mammario …web2.sacrocuore.it/oncologia/canoa2015/VENERDI_10... · Migration Differentiation Apoptosis Trastuzumab ... Pathologic complete

Page 17: Trattamento neoadiuvante del carcinoma mammario …web2.sacrocuore.it/oncologia/canoa2015/VENERDI_10... · Migration Differentiation Apoptosis Trastuzumab ... Pathologic complete

Page 18: Trattamento neoadiuvante del carcinoma mammario …web2.sacrocuore.it/oncologia/canoa2015/VENERDI_10... · Migration Differentiation Apoptosis Trastuzumab ... Pathologic complete

Page 19: Trattamento neoadiuvante del carcinoma mammario …web2.sacrocuore.it/oncologia/canoa2015/VENERDI_10... · Migration Differentiation Apoptosis Trastuzumab ... Pathologic complete

Back-up slides

Page 20: Trattamento neoadiuvante del carcinoma mammario …web2.sacrocuore.it/oncologia/canoa2015/VENERDI_10... · Migration Differentiation Apoptosis Trastuzumab ... Pathologic complete

Page 21: Trattamento neoadiuvante del carcinoma mammario …web2.sacrocuore.it/oncologia/canoa2015/VENERDI_10... · Migration Differentiation Apoptosis Trastuzumab ... Pathologic complete

Page 22: Trattamento neoadiuvante del carcinoma mammario …web2.sacrocuore.it/oncologia/canoa2015/VENERDI_10... · Migration Differentiation Apoptosis Trastuzumab ... Pathologic complete

Page 23: Trattamento neoadiuvante del carcinoma mammario …web2.sacrocuore.it/oncologia/canoa2015/VENERDI_10... · Migration Differentiation Apoptosis Trastuzumab ... Pathologic complete

Page 24: Trattamento neoadiuvante del carcinoma mammario …web2.sacrocuore.it/oncologia/canoa2015/VENERDI_10... · Migration Differentiation Apoptosis Trastuzumab ... Pathologic complete

Page 25: Trattamento neoadiuvante del carcinoma mammario …web2.sacrocuore.it/oncologia/canoa2015/VENERDI_10... · Migration Differentiation Apoptosis Trastuzumab ... Pathologic complete

Page 26: Trattamento neoadiuvante del carcinoma mammario …web2.sacrocuore.it/oncologia/canoa2015/VENERDI_10... · Migration Differentiation Apoptosis Trastuzumab ... Pathologic complete

Page 27: Trattamento neoadiuvante del carcinoma mammario …web2.sacrocuore.it/oncologia/canoa2015/VENERDI_10... · Migration Differentiation Apoptosis Trastuzumab ... Pathologic complete

Page 28: Trattamento neoadiuvante del carcinoma mammario …web2.sacrocuore.it/oncologia/canoa2015/VENERDI_10... · Migration Differentiation Apoptosis Trastuzumab ... Pathologic complete

Page 29: Trattamento neoadiuvante del carcinoma mammario …web2.sacrocuore.it/oncologia/canoa2015/VENERDI_10... · Migration Differentiation Apoptosis Trastuzumab ... Pathologic complete

Page 30: Trattamento neoadiuvante del carcinoma mammario …web2.sacrocuore.it/oncologia/canoa2015/VENERDI_10... · Migration Differentiation Apoptosis Trastuzumab ... Pathologic complete

Page 31: Trattamento neoadiuvante del carcinoma mammario …web2.sacrocuore.it/oncologia/canoa2015/VENERDI_10... · Migration Differentiation Apoptosis Trastuzumab ... Pathologic complete

Top Related

Máster Universitario en Biotecnología Sanitaria Máster ......apoptosis). Telómeros y la inestabilidad estructural de los cromosomas. Cambios metabólicos, efecto Warburg. Inducción

Máster Universitario en Biotecnología Sanitaria Máster ......apoptosis). Telómeros y la inestabilidad estructural de los cromosomas. Cambios metabólicos, efecto Warburg. Inducción

Terapie mediche adiuvanti - Rete Oncologica Piemonte · TRASTUZUMAB: LA STORIA DI UN FARMACO DI SUCCESSO ... L’oncologo valuta lo stato funzionale della paziente (aspetti internistici,

Terapie mediche adiuvanti - Rete Oncologica Piemonte · TRASTUZUMAB: LA STORIA DI UN FARMACO DI SUCCESSO ... L’oncologo valuta lo stato funzionale della paziente (aspetti internistici,

Low body temperature governs the decline of circulating …spleen during torpor or substantial apoptosis of these cells. Sur-gical removal of the spleen (splenectomy) preceding the

Low body temperature governs the decline of circulating …spleen during torpor or substantial apoptosis of these cells. Sur-gical removal of the spleen (splenectomy) preceding the

Testi del Syllabus - Unical · Role of root in water uptake. - Ontogeny. Tunica-corpus theory. Differentiation of protoderma, fundamental meristem and procambium. Anatomy of primary

Testi del Syllabus - Unical · Role of root in water uptake. - Ontogeny. Tunica-corpus theory. Differentiation of protoderma, fundamental meristem and procambium. Anatomy of primary

UNIVERSITA’ DEGLI STUDI DI MODENA E REGGIO … · Operational closure and structural coupling: the differentiation of the legal system , Cardozo Law Review, 13(5), 1992, 1419-1441.

UNIVERSITA’ DEGLI STUDI DI MODENA E REGGIO … · Operational closure and structural coupling: the differentiation of the legal system , Cardozo Law Review, 13(5), 1992, 1419-1441.

Trastuzumab (Herceptin®) - biotec.campusnet.unito.it · Apparato Respiratorio:asma, aumento della tosse, dispnea, epistassi, disturbi polmonari, faringite, rinite, sinusite ... •

Trastuzumab (Herceptin®) - biotec.campusnet.unito.it · Apparato Respiratorio:asma, aumento della tosse, dispnea, epistassi, disturbi polmonari, faringite, rinite, sinusite ... •

s Cutaneous invasion from sarcomatoid urothelial carcinoma ......The invasive urothelial carcinoma is rec - ognized for its ability to present divergent differentiation and morphological

s Cutaneous invasion from sarcomatoid urothelial carcinoma ......The invasive urothelial carcinoma is rec - ognized for its ability to present divergent differentiation and morphological

FACOLTÀ DI FARMACIA Corso di Laurea Magistrale in Farmacia … · 2017-03-21 · 1.1.1.2 Anticorpi monoclonali anti-HER-2 Trastuzumab è un anticorpo umanizzato IgG1 indicato nel

FACOLTÀ DI FARMACIA Corso di Laurea Magistrale in Farmacia … · 2017-03-21 · 1.1.1.2 Anticorpi monoclonali anti-HER-2 Trastuzumab è un anticorpo umanizzato IgG1 indicato nel